Finally, we have received notice that numerous non-shareholders whose lives have been saved -- and others who cannot afford to travel to a screening event -- will be intervening in the current lawsuits and suing brokerage houses and co-conspiratorial lawyers for preventing them from obtaining potentially life-saving heart screenings. We do not know who will be representing these human beings and have no further knowledge related thereto.
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices, therapies and/or technologies that simplify and reduce the costs of cardiovascular disease.
Signalife, Inc. is traded on the American Stock Exchange under the symbol SGN. More information is located at http://www.signalife.com. Clear Data. Trusted Results.
Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are
"forward-looking" statements. Forward-looking statements involve known and
unknown risks, which may cause the companies' actual results in the future
to differ materially from expected results. Factors which could cause or
contribute to such differences include, but are not limited to, failure to
complete the development and introduction of heart monitoring and other
biomedical devices incorporating the companies' technology procure market
acceptance for these products, failure to obtain federal or
|SOURCE Signalife, Inc.|
Copyright©2008 PR Newswire.
All rights reserved